Survey finds 50 per cent of UK’s R&D spend is within pharma

About The Authors

10th November 2016 11:52 - Pharmaceutical

Survey finds 50 per cent of UK’s R&D spend is within pharma: According to a pharmaceutical survey by PwC - which analysed 1,000 large corporations - some 50 per cent of all corporate research and development spending in the United Kingdom has been conducted within the healthcare and pharmaceutical industries. This trend is expected to occur again around the world in the coming years.Survey finds 50 per cent of UK’s R&D spend is within pharma

Behind the vast majority of the industry’s investment are GlaxoSmithKline and AstraZeneca, making up £7.5billion of the £7.9billion spent in total. The healthcare and pharmaceutical industries was found to make up 48 per cent of all corporate research and development in the United Kingdom.

The pharmaceuticals industry is currently being moulded by issues such as aging populations and the demand for more sophisticated treatments, as well as the Government initiative, the Accelerated Access Review, which helps speed up the rate in which drugs are able to enter the market. PwC said that these issues are expected to drive an increase in spending that will make the healthcare and pharmaceuticals industries the largest source of global research and development by 2018.

Worldwide, the healthcare and pharmaceuticals sectors make up approximately one fifth of research and development.

Investment in research and development does not only drive technological improvements, but it is a core driver in increasing productivity and economic wealth.

The healthcare industry is one of the three sectors which PwC has tracked since 2005 and in that time, research and development spend has increased year on year.

Even though GlaxoSmithKline and AstraZeneca have a combined UK investment of £7.9billion, neither of the companies have made it onto the list of the top five global pharmaceutical spenders. At the top of the list is Roche and Novartis of Switzerland.

Sign up for free insights from your sector…

Antispam code: 6454

Support Us..

We hope that you have found this article useful. This section is freely available for all to use. Please help support it by liking us or following us on our social media platforms:

Share this article..

For updated Pharmaceutical insights please follow us on @DJS_Pharma or use our RSS feed

Other Pharmaceutical Research Findings

Other Latest Market Research Insights

© DJS Research 2017